According to a new market report published by Lucintel, the future of the hematology diagnostic market looks promising with opportunities in hospitals and diagnostic labs. The global hematology diagnostic market is expected to grow with a CAGR of 6% from 2020 to 2025. The major drivers for this market are development of technologically advanced hematology analyzers, increasing usage of flow cytometry in hematology testing, and development of high-sensitivity point-of-care hematology analyzers.
To download report brochure, please go to https://www.lucintel.com/hematology-diagnostic-market.aspx and click "download brochure" tab from the menu
Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. In this market, instruments and comsumables are the major products of hematology diagnostic. Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rise in diagnosis of blood disorders and other infections and increasing test volume owing to rising awareness and early detection.
Within this market, hospitals will remain the largest end user segment over the forecast period due to high patient influx in hospitals and a growing number of registered hospitals across the globe.
North America will remain the largest region over the forecast period due to technological advancements in instruments, ease of usage, and favorable reimbursement scenario.
Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Boule Diagnostics, Horiba, Mindray Medical, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation are among the major suppliers in the global hematology diagnostic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global hematology diagnostic market by product, test, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Hematology Diagnostic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global hematology diagnostic market by product, test, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
By Test [Value ($ Million) shipment analysis for 2014 – 2025]:
CBC
Hemoglobin
Hematocrit
RBC
WBC
Reticulocytes
Platelet Function
CRP
Neutrophil Function
Bone Marrow
DPG
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Diagnostic Labs
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.